Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Farzaneh Barkhordari, Nooshin Sohrabi, Fatemeh Davami, Fereidoun Mahboudi & Yeganeh Talebkhan Garoosi. (2019) Cloning, expression and characterization of a HER2-alpha luffin fusion protein in Escherichia coli. Preparative Biochemistry & Biotechnology 49:8, pages 759-766.
Read now
Read now
Xiaoming Ouyang, Ashley Barling, Aletha Lesch, Jeffrey W. Tyner, Gabrielle Choonoo, Christina Zheng, Sophia Jeng, Toni M. West, Daniel Clayburgh, Sara A. Courtneidge, Shannon K. McWeeney & Molly Kulesz-Martin. (2018) Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models. Cancer Biology & Therapy 19:10, pages 921-933.
Read now
Read now
Rajeev Nema, Supriya Vishwakarma, Rahul Agarwal, Rajendra Kumar Panday & Ashok Kumar. (2016) Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma. OncoTargets and Therapy 9, pages 3269-3280.
Read now
Read now
Articles from other publishers (66)
Wenqi Ma, Ronghan Liu, Kai Zhao & Jiangbo Zhong. (2023) Vital role of SHMT2 in diverse disease. Biochemical and Biophysical Research Communications 671, pages 160-165.
Crossref
Crossref
Kimberly J. Jasmer, Kevin Muñoz Forti, Lucas T. Woods, Seunghee Cha & Gary A. Weisman. (2022) Therapeutic potential for P2Y2 receptor antagonism. Purinergic Signalling 19:2, pages 401-420.
Crossref
Crossref
Christina Healthyni, Toto Subroto, Sandra Megantara, Supat Jiranusornkul & Jutti Levita. (2022) Potential use of lapatinib in the treatment of head and neck squamous cell carcinoma (Review). World Academy of Sciences Journal 4:5.
Crossref
Crossref
Yanli Jin, Seung-Nam Jung, Mi Ae Lim, Chan Oh, Yudan Piao, Hae Jong Kim, QuocKhanh Nguyena, Yea Eun Kang, Jae Won Chang, Ho-Ryun Won & Bon Seok Koo. (2022) SHMT2 Induces Stemness and Progression of Head and Neck Cancer. International Journal of Molecular Sciences 23:17, pages 9714.
Crossref
Crossref
DeannaLee M. Beauvais, Scott E. Nelson, Kristin M. Adams, Noah A. Stueven, Oisun Jung & Alan C. Rapraeger. (2022) Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression. Journal of Biological Chemistry 298:6, pages 102029.
Crossref
Crossref
Anuja Deshmukh, Karthik Nagaraja Rao, Ripu Daman Arora, Nitin M. Nagarkar, Ambesh Singh & Om Shree Shetty. (2021) Molecular Insights into Oral Malignancy. Indian Journal of Surgical Oncology 13:2, pages 267-280.
Crossref
Crossref
Stefania Crucitta, Federico Cucchiara, Ron Mathijssen, Joaquin Mateo, Agnes Jager, Arjen Joosse, Antonio Passaro, Ilaria Attili, Iacopo Petrini, Ron van Schaik, Romano Danesi & Marzia Del Re. (2022) Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours. Cancer Treatment Reviews 104, pages 102340.
Crossref
Crossref
Concetta Altamura, Paola Gavazzo, Michael Pusch & Jean-François Desaphy. (2022) Ion Channel Involvement in Tumor Drug Resistance. Journal of Personalized Medicine 12:2, pages 210.
Crossref
Crossref
Richard Lee, Nicolas Girard & Sanjay Popat. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
844
852
.
Adi Jacob Berger, Elinor Gigi, Lana Kupershmidt, Zohar Meir, Nancy Gavert, Yaara Zwang, Amir Prior, Shlomit Gilad, Uzi Harush, Izhak Haviv, Salomon M. Stemmer, Galia Blum, Emmanuelle Merquiol, Mariya Mardamshina, Sivan Kaminski Strauss, Gilgi Friedlander, Jair Bar, Iris Kamer, Yitzhak Reizel, Tamar Geiger, Yitzhak Pilpel, Yishai Levin, Amos Tanay, Baruch Barzel, Hadas Reuveni & Ravid Straussman. (2021) IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy. Nature Cancer 2:10, pages 1055-1070.
Crossref
Crossref
Yanli Jin, Seung-Nam Jung, Mi Ae Lim, Chan Oh, Yudan Piao, Hae Jong Kim, Lihua Liu, Yea Eun Kang, Jae Won Chang, Ho-Ryun Won, Kunho Song & Bon Seok Koo. (2021) Transcriptional Regulation of GDF15 by EGR1 Promotes Head and Neck Cancer Progression through a Positive Feedback Loop. International Journal of Molecular Sciences 22:20, pages 11151.
Crossref
Crossref
Yuchen Bai, Jarryd Boath, Gabrielle R. White, Uluvitike G. I. U. Kariyawasam, Camile S. Farah & Charbel Darido. (2021) The Balance between Differentiation and Terminal Differentiation Maintains Oral Epithelial Homeostasis. Cancers 13:20, pages 5123.
Crossref
Crossref
M. S. Sinto, Shaji Thomas & S. Kannan. (2021) Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis. Medical Oncology 38:9.
Crossref
Crossref
Julián F. Beltran, SM Viafara-Garcia, Alberto P. Labrador & Johan Basterrechea. (2021) The Role of Periodontopathogens and Oral Microbiome in the Progression of Oral Cancer. A Review. The Open Dentistry Journal 15:1, pages 367-376.
Crossref
Crossref
Christine Goudsmit, Felipe da Veiga Leprevost, Venkatesha Basrur, Lila Peters, Alexey Nesvizhskii & Heather Walline. (2021) Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status. Cancers 13:15, pages 3714.
Crossref
Crossref
Hechen Wang, Tianyu Wang, Zeying Zhang, Yu Fan, Lan Zhang, Kuan Gao, Shuya Luo, Qinghuan Xiao & Changfu Sun. (2021) Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca2+-activated chloride channel. Journal of Cancer Research and Clinical Oncology 147:6, pages 1699-1711.
Crossref
Crossref
Madhuri Grover, Tapan Behl, Monika Sachdeva, Simona Bungao, Lotfi Aleya & Dhruv Setia. (2021) Focus on Multi-targeted Role of Curcumin: a Boon in Therapeutic Paradigm. Environmental Science and Pollution Research 28:15, pages 18893-18907.
Crossref
Crossref
Wenjian Chen, Meng Gu, Chaobing Gao, Bangjie Chen, Junfa Yang, Xiaoli Xie, Xinyi Wang, Jun Sun & Jinian Wang. (2021) The Prognostic Value and Mechanisms of TMEM16A in Human Cancer. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Saima Usman, Ahmad Jamal, Muy-Teck Teh & Ahmad Waseem. (2021) Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance. Frontiers in Oral Health 1.
Crossref
Crossref
Morena Fasano, Carminia Maria Della Corte, Giuseppe Viscardi, Raimondo Di Liello, Fernando Paragliola, Francesca Sparano, Maria Lucia Iacovino, Anna Castrichino, Francesca Doria, Antonello Sica, Floriana Morgillo, Giuseppe Colella, Giampaolo Tartaro, Salvatore Cappabianca, Domenico Testa, Gaetano Motta & Fortunato Ciardiello. (2021) Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy. Therapeutic Advances in Medical Oncology 13, pages 175883592094941.
Crossref
Crossref
Ines De Pauw, Carolien Boeckx & An Wouters. 2021. Critical Issues in Head and Neck Oncology. Critical Issues in Head and Neck Oncology
21
51
.
Yang Zheng, An Song, Yan Zhou, Yi Zhong, Wei Zhang, Chundi Wang, Xu Ding, Yifei Du, Wei Zhang, Gang Li, Heming Wu, Yunong Wu & Xiaomeng Song. (2020) Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma. Journal of Cell Communication and Signaling 14:4, pages 389-402.
Crossref
Crossref
Won Jong Jin, Amy K. Erbe, Ciara N. Schwarz, Abigail A. Jaquish, Bryce R. Anderson, Raghava N. Sriramaneni, Justin C. Jagodinsky, Amber M. Bates, Paul A. Clark, Trang Le, Keng-Hsueh Lan, Yi Chen, KyungMann Kim & Zachary S. Morris. (2020) Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology 11.
Crossref
Crossref
Barbara A. Frederick, Rohit Gupta, Amandla Atilano-Roque, Tin Tin Su & David Raben. (2020) Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models. Radiation Research 194:5.
Crossref
Crossref
Aarushi Sharma & Randolph C. Elble. (2020) From Orai to E-Cadherin: Subversion of Calcium Trafficking in Cancer to Drive Proliferation, Anoikis-Resistance, and Metastasis. Biomedicines 8:6, pages 169.
Crossref
Crossref
Rachel A. O’Keefe, Neil E. Bhola, David S. Lee, Daniel E. Johnson & Jennifer R. Grandis. (2020) Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance. PLOS ONE 15:1, pages e0227261.
Crossref
Crossref
Jose M. Ayuso, Ross Vitek, Adam D. Swick, Melissa C. Skala, Kari B. Wisinski, Randall J. Kimple, Paul F. Lambert & David J. Beebe. (2019) Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells. Scientific Reports 9:1.
Crossref
Crossref
S. Kareemaghay & M. Tavassoli. (2019) Clinical immunotherapeutic approaches for the treatment of head and neck cancer. International Journal of Oral and Maxillofacial Surgery 48:4, pages 419-436.
Crossref
Crossref
Zhipeng Li, Jipei Liao, Zejia Yang, Eun Yong Choi, Rena G. Lapidus, Xuefeng Liu, Kevin J. Cullen & Hancai Dan. (2018) Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer 120:3, pages 306-316.
Crossref
Crossref
Gopinath M. Sundaram, Shan Quah & Prabha Sampath. (2018) Cancer: the dark side of wound healing. The FEBS Journal 285:24, pages 4516-4534.
Crossref
Crossref
Xu Qian, Xiaobo Nie, Wenhao Yao, Konrad Klinghammer, Holger Sudhoff, Andreas M. Kaufmann & Andreas E. Albers. (2018) Reactive oxygen species in cancer stem cells of head and neck squamous cancer. Seminars in Cancer Biology 53, pages 248-257.
Crossref
Crossref
Chin‑Fu ChenChi‑Cheng LuJo‑Hua ChiangHong‑Yi ChiuJai‑Sing YangChao‑Ying LeeTzong‑Der WayHao‑Jen Huang. (2018) Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin‑resistant oral cancer CAR cells through intrinsic apoptotic process. Oncology Letters.
Crossref
Crossref
Denis Soulières, Lisa Licitra, Ricard Mesía, Éva Remenár, Shau-Hsuan Li, Andrey Karpenko, Marie Chol, Ying A. Wang, Nadia Solovieff, Laurence Bourdeau, Dalila Sellami & Sandrine Faivre. (2018) Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1. Clinical Cancer Research 24:11, pages 2505-2516.
Crossref
Crossref
Jinlong Yin, Ji-Eun Jung, Sun Il Choi, Sung Soo Kim, Young Taek Oh, Tae-Hoon Kim, Eunji Choi, Sun Joo Lee, Hana Kim, Eun Ok Kim, Yu Sun Lee, Hee Jin Chang, Joo Yong Park, Yeejeong Kim, Tak Yun, Kyun Heo, Youn-Jae Kim, Hyunggee Kim, Yun-Hee Kim, Jong Bae Park & Sung Weon Choi. (2018) Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas. Cancer Letters 414, pages 181-189.
Crossref
Crossref
Wendy D'SouzaDhananjaya Saranath. (2017) OMICS, Oral Cancer Molecular Landscapes, and Clinical Practice. OMICS: A Journal of Integrative Biology 21:12, pages 689-703.
Crossref
Crossref
Andrew M. Overmiller, Jennifer A. Pierluissi, Peter J. Wermuth, Sami Sauma, Ubaldo Martinez‐Outschoorn, Madalina Tuluc, Adam Luginbuhl, Joseph Curry, Larry A. Harshyne, James K. WahlIIIIII, Andrew P. South & Mỹ G. Mahoney. (2017) Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes. The FASEB Journal 31:8, pages 3412-3424.
Crossref
Crossref
Sucheta Kulkarni, Anke Bill, Neal R. Godse, Nayel I. Khan, Jason I. Kass, Kevin Steehler, Carolyn Kemp, Kara Davis, Carol A. Bertrand, Avani R. Vyas, Douglas E. Holt, Jennifer R. Grandis, L Alex Gaither & Umamaheswar Duvvuri. (2017) TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2. Genes, Chromosomes and Cancer 56:6, pages 460-471.
Crossref
Crossref
Susanne R. Tepper, Zhixiang Zuo, Arun Khattri, Jochen Heß & Tanguy Y. Seiwert. (2016) Growth factor expression mediates resistance to EGFR inhibitors in head and neck squamous cell carcinomas. Oral Oncology 56, pages 62-70.
Crossref
Crossref
Martina Raudenska, Jaromir Gumulec, Andrew M. Fribley & Michal Masarik. 2016. Targeting Oral Cancer. Targeting Oral Cancer
115
160
.
Insoon Chang, Aasia O. Rehman & Cun-Yu Wang. 2016. Targeting Oral Cancer. Targeting Oral Cancer
71
99
.
R. Bryan Bell, Rom Leidner, Zipei Feng, Marka R. Crittenden, Michael J. Gough & Bernard A. Fox. (2015) Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma. Journal of Oral and Maxillofacial Surgery 73:12, pages S107-S115.
Crossref
Crossref
Laura K. van Dijk, Otto C. Boerman, Johannes H.A.M. Kaanders & Johan Bussink. (2015) PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging. Clinical Cancer Research 21:16, pages 3602-3609.
Crossref
Crossref
Anke Bill, Abraham Gutierrez, Sucheta Kulkarni, Carolyn Kemp, Debora Bonenfant, Hans Voshol, Umamaheswar Duvvuri & L. Alex Gaither. (2015) ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Oncotarget 6:11, pages 9173-9188.
Crossref
Crossref
Ying Xiang, Qiying Li, Dehong Huang, Xianjun Tang, Li Wang, Yang Shi, Wenjun Zhang, Tao Yang, Chunyan Xiao & Jianghong Wang. (2014) Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator. Experimental Biology and Medicine 240:2, pages 160-168.
Crossref
Crossref
Naresh Somani. (2015) Nimotuzumab with Concurrent Chemo-Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). Journal of Cancer Therapy 06:04, pages 356-361.
Crossref
Crossref
Hiroki Sato, Kanako C Hatanaka, Yutaka Hatanaka, Hiromitsu Hatakeyama, Ari Hashimoto, Yoshihiro Matsuno, Satoshi Fukuda & Hisataka Sabe. (2014) High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients. Cell Communication and Signaling 12:1.
Crossref
Crossref
Zhiyong Wang, Daniel Martin, Alfredo A. Molinolo, Vyomesh Patel, Ramiro Iglesias-Bartolome, Maria Sol Degese, Lynn Vitale-Cross, Qianming Chen & J. Silvio Gutkind. (2014) mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations. JNCI: Journal of the National Cancer Institute 106:9.
Crossref
Crossref
X. Varelas, M. P. Bouchie & M. A. Kukuruzinska. (2014) Protein N-glycosylation in oral cancer: Dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. Glycobiology 24:7, pages 579-591.
Crossref
Crossref
SHINSUKE SUZUKI & KAZUO ISHIKAWA. (2014) Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells. International Journal of Oncology 44:3, pages 912-917.
Crossref
Crossref
Anja Pickhard, Guido Piontek, Christof Seidl, Samuel Kopping, Birgit Blechert, Martin Mißlbeck, Gero Brockhoff, Frank Bruchertseifer, Alfred Morgenstern & Markus Essler. (2014) 213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells. Nuclear Medicine and Biology 41:1, pages 68-76.
Crossref
Crossref
Patricia Severino, Holger Brüggemann, Flavia Maziero Andreghetto, Carme Camps, Maria de Fatima Garrido Klingbeil, Welbert Oliveira de Pereira, Renata Machado Soares, Raquel Moyses, Victor Wünsch-Filho, Monica Beatriz Mathor, Fabio Daumas Nunes, Jiannis Ragoussis & Eloiza Helena Tajara. (2013) MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation. BMC Cancer 13:1.
Crossref
Crossref
Fahad Kidwai, Daniela E. Costea, Iain Hutchison & Ian Mackenzie. (2013) The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines. Journal of Oral Pathology & Medicine 42:9, pages 682-690.
Crossref
Crossref
I. Garcia, R. Kuska & M.J. Somerman. (2013) Expanding the Foundation for Personalized Medicine. Journal of Dental Research 92:7_suppl, pages S3-S10.
Crossref
Crossref
Sufi M. Thomas, Bichismita Sahu, Srinivas Rapireddy, Raman Bahal, Sarah E. Wheeler, Eva M. Procopio, Joseph Kim, Sonali C. Joyce, Sarah Contrucci, Yun Wang, Simion I. Chiosea, Kira L. Lathrop, Simon Watkins, Jennifer R. Grandis, Bruce A. Armitage & Danith H. Ly. (2012) Antitumor Effects of EGFR Antisense Guanidine-Based Peptide Nucleic Acids in Cancer Models. ACS Chemical Biology 8:2, pages 345-352.
Crossref
Crossref
Michelle Lenarduzzi, Angela B. Y. Hui, Nehad M. Alajez, Wei Shi, Justin Williams, Shijun Yue, Brian O’Sullivan & Fei-Fei Liu. (2013) MicroRNA-193b Enhances Tumor Progression via Down Regulation of Neurofibromin 1. PLoS ONE 8:1, pages e53765.
Crossref
Crossref
Annelies W Turksma, Boudewijn JM Braakhuis, Elisabeth Bloemena, Chris JLM Meijer, C René Leemans & Erik Hooijberg. (2013) Immunotherapy for head and neck cancer patients: shifting the balance. Immunotherapy 5:1, pages 49-61.
Crossref
Crossref
Katie Twigger, Victoria Roulstone, Joan Kyula, Eleni M Karapanagiotou, Konstantinos N Syrigos, Richard Morgan, Christine White, Shreerang Bhide, Gerard Nuovo, Matt Coffey, Brad Thompson, Adel Jebar, Fiona Errington, Alan A Melcher, Richard G Vile, Hardev S Pandha & Kevin J Harrington. (2012) Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer 12:1.
Crossref
Crossref
Young-Soon Na, Soo-Jin Yang, Seung-Mi Kim, Kyung-Ah Jung, Jai-Hee Moon, Jae-Sik Shin, Dok Hyun Yoon, Yong Sang Hong, Min-Hee Ryu, Jae-Lyun Lee, Jung Shin Lee & Tae Won Kim. (2012) YM155 Induces EGFR Suppression in Pancreatic Cancer Cells. PLoS ONE 7:6, pages e38625.
Crossref
Crossref
Chengyuan Ma, Yang Li, Zhixin Li, Haiyan Huang, Kan Xu, Haiyang Xu, Jieying Bai, Xiao Li & Gang Zhao. (2012) Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli. Protein Expression and Purification 83:1, pages 1-7.
Crossref
Crossref
Satoshi Fukuda & Hiromitsu Hatakeyama. (2012) Current Research into Head and Neck Cancer Molecular Targeted Therapy and Human Papilloma Virus Infection in Head and Neck Squamous Cell Carcinoma. Practica Oto-Rhino-Laryngologica 105:3, pages 183-191.
Crossref
Crossref
Akshar N. PatelJanice M. MehnertSung Kim. (2012) Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab. Clinical Medicine Insights: Ear, Nose and Throat 5, pages CMENT.S5129.
Crossref
Crossref
Ajay Matta & Ranju Ralhan. 2012. Controversies in Oral Cancer. Controversies in Oral Cancer
1
16
.
Anja C Pickhard, Johanna Margraf, Andreas Knopf, Thomas Stark, Guido Piontek, Carolin Beck, Anne-Laure Boulesteix, Elias Q Scherer, Steffi Pigorsch, Jürgen Schlegel, Wolfgang Arnold & Rudolf Reiter. (2011) Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways. BMC Cancer 11:1.
Crossref
Crossref
Ethan R. Block, Michael A. Tolino & Jes K. Klarlund. (2011) Extracellular ATP stimulates epithelial cell motility through Pyk2-mediated activation of the EGF receptor. Cellular Signalling 23:12, pages 2051-2055.
Crossref
Crossref
Dipankar Ray, Aarif Ahsan, Abigail Helman, Guoan Chen, Ashok Hegde, Susmita Ramanand Gurjar, Lili Zhao, Hiroaki Kiyokawa, David G Beer, Theodore S Lawrence & Mukesh K Nyati. (2011) Regulation of EGFR Protein Stability by the HECT-type Ubiquitin Ligase SMURF2. Neoplasia 13:7, pages 570-IN1.
Crossref
Crossref
Joseph Knowles, Hope Heath, Reshu Saini, Heidi Umphrey, Eben Rosenthal & Kenneth Hoyt. (2010) Epidermal growth factor receptor targeting using cetuximab labeled ultrasound contrast agents — A feasibility study. Epidermal growth factor receptor targeting using cetuximab labeled ultrasound contrast agents — A feasibility study.